Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo (CQI-PMTCT)
Continuous Quality Improvement Interventions to Improve Long Term Outcomes of Antiretroviral Therapy in Women Initiated on Therapy During Pregnancy or Breastfeeding in the Democratic Republic of Congo
Sponsor: Albert Einstein College of Medicine
This NA trial investigates Antiretroviral Therapy and HIV-exposed Infants and is currently completed. Albert Einstein College of Medicine leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Jun 2025 — Sep 2025 [monthly]
Completed NA
-
Sep 2024 — Jun 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 8 earlier versions
-
Oct 2021 — Sep 2022 [monthly]
Recruiting NA
-
Sep 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Nov 2019 — Jan 2021 [monthly]
Recruiting NA
-
Oct 2019 — Nov 2019 [monthly]
Recruiting NA
-
Jun 2018 — Oct 2019 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2017 — May 2018 [monthly]
Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Albert Einstein College of Medicine
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Kinshasa School of Public Health
For direct contact, visit the study record on ClinicalTrials.gov .